Industry

Private Label Brand Compliance

Your name is on the package and someone else's plant made it. Oversight of the co-manufacturer is the whole job, and a certificate on file is not oversight.

Risks mapped
5 primary risks
Regulatory references
5 cited
Structure
Risk → Regulation → Solution

Context

Where private label brands get caught out

Private label and contract-manufactured brands carry a structural mismatch: reputational and commercial responsibility sits with the brand, while operational control sits with the manufacturer. When something goes wrong, the recall is announced under your name.

The controls that close that gap are unglamorous — specifications that are actually agreed rather than assumed, a quality agreement that allocates responsibility explicitly, a real qualification and audit programme, and label change control that runs through you rather than around you.

01 — Risk

What actually goes wrong.

Ranked by consequence rather than by how visible or convenient the fix is. Relative exposure levels below are SURU's professional assessment of typical operations in this segment — not a regulatory classification, and not a rating of your specific business.

  • Recalls announced under your brand

    Critical exposure

    Consumers, retailers and media attribute the failure to the name on the label. Your ability to demonstrate diligent oversight matters commercially and in every conversation that follows.

  • Specifications assumed rather than agreed

    High exposure

    Where finished product specifications, allergen status and ingredient sourcing were never documented and mutually accepted, disputes over what was supposed to happen are unresolvable.

  • Label control living at the manufacturer

    Critical exposure

    If your co-manufacturer can change a formulation or a supplier without triggering a label review on your side, an undeclared allergen becomes a matter of time.

  • Certificate-on-file oversight

    High exposure

    An annual certification certificate is evidence that a manufacturer passed an audit on one day. It is not a supplier approval program, and retail customers increasingly say so directly.

  • Multi-manufacturer inconsistency

    Moderate exposure

    The same SKU produced at two plants often diverges in process, sourcing and allergen profile, producing product that meets neither one specification nor a single label.

02 — Regulation

What the rules typically require.

These are the frameworks that most often apply to this kind of operation. Exemptions, modified requirements and jurisdictional differences are common, so applicability has to be confirmed against your specific products and operations.

Educational summaries only. Not legal advice, and not a substitute for the regulation text, your regulatory authority's guidance, or qualified counsel.

21 CFR Part 117 Subpart G
Supply-chain program requirements where a hazard requiring a preventive control is controlled before receipt — supplier approval, verification activity and documented review.
21 CFR Part 101 and FALCPA
Labeling accuracy including ingredient declaration and major food allergens. The responsible party named on the label carries the misbranding exposure.
21 CFR Part 7 Subpart C and the Reportable Food Registry
Recall procedures and reportable food obligations. Brand owners need their own recall plan, not only their manufacturer's.
21 CFR Part 1 Subpart L
Where the product or its ingredients are imported, FSVP obligations may sit with you rather than with the manufacturer, depending on the import structure.
21 CFR Part 111 for supplement brands
Brand owners that hold or label dietary supplements can fall within Part 111 scope in their own right, separate from their contract manufacturer's obligations.

03 — SURU solution

What we do about it.

Scoped to your operation, sequenced so each step earns the next, and delivered with the documentation you will need when someone asks you to prove it.

  1. Specification and quality agreement build

    Finished product, ingredient, packaging and label specifications documented and mutually accepted, with a quality agreement that says who does what — including who may change what.

  2. Manufacturer qualification and audit program

    Documentation-based qualification plus onsite audits at a frequency matched to risk, with findings tracked to closure rather than filed.

  3. Label change control anchored at the brand

    A gated process where any formulation, supplier or process change triggers label review on your side before it reaches production.

  4. Brand-side recall readiness

    Your own recall plan and contact tree, tested by a mock exercise that includes your manufacturer, so the first joint exercise is not the real one.

  5. Multi-plant harmonisation

    Where a SKU is produced at more than one facility, alignment of process, sourcing and allergen status so one label remains accurate everywhere.

We do not promise inspection outcomes, audit scores, certification results or regulatory findings. Those decisions rest with regulators, certification bodies and auditors.

05 — Private Label Brands

Talk to us about your private label brands operation.

Tell us what you run, where you run it, and what is coming — a re-inspection, a customer audit, a first import, a certification deadline. We will tell you what applies and what it takes to be ready.

Direct contact

SURU Compliance is a regulatory consulting practice. We are not a government agency, a certification body, or a law firm, and we do not provide legal advice or guarantee regulatory outcomes.